Background: Measurement of C-reactive protein(CRP), a marker of inflammation, is recommended to improve cardiovascular disease(CVD)risk stratification. However,
Aims: To determine the presence and extent of delayed contrast enhancement(DCE) in patients with pulmonary hypertension(PHT) using contrast enhanced-cardiovascu